imodium and glp-1 IMODIUM® Multi-Symptom Relief Caplets for Diarrhea Relief Clinical Recommendations to Manage Gastrointestinal

A: Foundayo (orforglipron) is an oral GLP-1 receptor agonist (a daily pill)

Most users report significantly reduced hunger within the first two to four weeks, which naturally leads to smaller portion sizes without requiring intense willpower or strict calorie counting

Key Takeaways If youre asking why GLP-1 isnt working or why GLP-1 doesnt work, the reasons may include unrealistic expectations, lifestyle factors, dosage, or underlying health conditions

However, avoid promising that the medication will reduce drinking

Most common side effects of orforglipron In phase 2 and phase 3 trials, the most frequently reported side effects were: Nausea Diarrhoea Constipation Vomiting Indigestion/dyspepsia These usually appeared during dose escalation and often settled as the body adjusted